Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 4205 participants.

Also called NCT07088523

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 4,205 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07088523
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07088523. Non-randomized; no masking; primary purpose treatment. Start 2025-07-31 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study
Acronym
TICDEs
Condition
Diabete Mellitus
Condition
Ischemic Cardiovascular Disease
Intervention (Drug)
Xintong Oral Liquid (Sequential Phase)
Intervention (Drug)
Xintong Oral Liquid (Intensive Phase)
Intervention (Drug)
TCM Syndrome Differentiation Decoction
Intervention (Drug)
Standard Treatment (Guideline-Based)
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct07088523
Content hash
5c214d50c5a78f7999c0ea8bfda80974e5f6387d988965a44e376f50969009a4